# G-BA - Gemeinsamer Bundesausschuss

This provider exposes tools and data accessible through its parent verticals. Use the example prompts as inspiration for your queries.

**Slug:** `gba`

**Description:** German early benefit assessments of new medicines (AMNOG, § 35a SGB V) from the G-BA's official machine-readable decision file: added-benefit category and certainty per patient group, comparator therapy, endpoint results and reasons, plus the latest procedure events.

## Verticals

This provider is available in the following verticals:

- [Medical](https://kirha.com/verticals/medical.md)

## Example prompts (non-exhaustive)

- `What added benefit did G-BA grant pembrolizumab in its latest assessments?`
- `Which orphan drugs got a considerable added benefit from G-BA in 2026?`
- `Compare the G-BA added benefit and comparator for semaglutide patient groups`
- `Which G-BA benefit assessment procedures had news this week?`

## Available tools in this provider

Open a tool to see its input and output schemas.

### [`listGbaProcedureUpdates`](https://kirha.com/providers/gba/listGbaProcedureUpdates.md)

List the latest events in G-BA benefit assessment procedures (about the 10 most recent): procedure started, dossier and IQWiG benefit assessment published with the comment deadline, procedure completed. Use for 'what changed recently' questions and for ongoing procedures not yet decided; decisions themselves are in searchGbaBenefitAssessments about a month after they are taken. Event texts are in German.

### [`getGbaBenefitAssessment`](https://kirha.com/providers/gba/getGbaBenefitAssessment.md)

Get full G-BA early benefit assessment decisions (AMNOG) by decision id: per patient group the comparator therapy, added-benefit category and certainty, the benefit statement, results per endpoint category (mortality, morbidity, quality of life, side effects) and G-BA's summary of reasons, plus ICD-10 codes and approval flags. Takes decisionIds from searchGbaBenefitAssessments.

### [`searchGbaBenefitAssessments`](https://kirha.com/providers/gba/searchGbaBenefitAssessments.md)

Search German G-BA early benefit assessment decisions (AMNOG, § 35a SGB V) by active substance (INN), trade name, ATC code, indication, added-benefit category and decision date. Returns, for each decision, the added-benefit category and certainty per patient group vs the appropriate comparator therapy. Use the decisionIds with getGbaBenefitAssessment for endpoint results and G-BA's reasons. Only decisions still in force are covered (repealed or superseded ones are dropped by G-BA); indication texts are in German, and substance matching tolerates English INN spelling (semaglutide finds Semaglutid). Prefer atcCode for cross-country joins.

-----

**Tags:** health, germany, hta, market access, amnog, medication, regulatory

[< Back to providers list](https://kirha.com/providers.md)